Article Type
Changed
Tue, 05/03/2022 - 16:08
Display Headline
Endocrinology update 2006
Article PDF
Author and Disclosure Information

S. Sethu K. Reddy, MD, MBA
Former chairman, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: S. Sethu K. Reddy, MD, MBA, FRCPC, Executive Director-Diabetes, External Medical and Scientific Affairs, Merck & Co., UG 3AB-30, 351 North Sumneytown Pike, North Wales, PA 19446; email [email protected]

Dr. Reddy has indicated that he was on the speakers’ bureaus of the GlaxoSmithKline, Lilly, Novartis, Sanofi-Aventis, and Takeda corporations. Subsequent to Dr. Reddy’s lecture, he accepted a position with Merck.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Issue
Cleveland Clinic Journal of Medicine - 73(11)
Publications
Topics
Page Number
1019-1024
Sections
Author and Disclosure Information

S. Sethu K. Reddy, MD, MBA
Former chairman, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: S. Sethu K. Reddy, MD, MBA, FRCPC, Executive Director-Diabetes, External Medical and Scientific Affairs, Merck & Co., UG 3AB-30, 351 North Sumneytown Pike, North Wales, PA 19446; email [email protected]

Dr. Reddy has indicated that he was on the speakers’ bureaus of the GlaxoSmithKline, Lilly, Novartis, Sanofi-Aventis, and Takeda corporations. Subsequent to Dr. Reddy’s lecture, he accepted a position with Merck.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Author and Disclosure Information

S. Sethu K. Reddy, MD, MBA
Former chairman, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic

Address: S. Sethu K. Reddy, MD, MBA, FRCPC, Executive Director-Diabetes, External Medical and Scientific Affairs, Merck & Co., UG 3AB-30, 351 North Sumneytown Pike, North Wales, PA 19446; email [email protected]

Dr. Reddy has indicated that he was on the speakers’ bureaus of the GlaxoSmithKline, Lilly, Novartis, Sanofi-Aventis, and Takeda corporations. Subsequent to Dr. Reddy’s lecture, he accepted a position with Merck.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(11)
Issue
Cleveland Clinic Journal of Medicine - 73(11)
Page Number
1019-1024
Page Number
1019-1024
Publications
Publications
Topics
Article Type
Display Headline
Endocrinology update 2006
Display Headline
Endocrinology update 2006
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media